Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity | Patent Number 07973031

US 07973031 B2
Application Number10493786
Publication NumberUS 20050020570 A1
Pendency8 years, 8 months, 11 days
Filled DateOct 29, 2002
Priority DateOct 30, 2001
Publication DateJan 27, 2005
Expiration DateOct 30, 2021
Inventor/ApplicantsPaul William Manley
James Douglas Griffin
ExaminesCOLEMAN, BRENDA LIBBY
Art Unit1624
Technology Center1600
Assignments
Novartis
Current
Novartis
Original
Danafarber Cancer Institute
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.